Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACCOSA: Oral Vinorelbine and Cisplatin with Radiotherapy in Elderly NSCLC
NCT01029678Phase 2Completed
- Sponsor
- CHU de Limoges
- Start
- Jan 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by CHU de Limoges. Primary endpoint: Acute toxicity. Started Jan 2010; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01029678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01029678.